Medtronic stock: Piper Sandler sets USD 85.00 target for Medtronic stock

Published on 10/21/2026 at 16:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Medtronic revenue reached USD 9.76 billion in fiscal Q1 2027, up 13.70 percent year over year. Medtronic stock costs EUR 83.69 on October 21, 2026.

Analyst target and reporting date

Piper Sandler maintained a Hold rating and a USD 85.00 target on October 14, 2026.
Fiscal Q1 2027 revenue reached USD 9.76 billion, up 13.70 percent year over year.
Medtronic stock was trading at EUR 83.69 at Lang & Schwarz on October 21, 2026 at 4:35 p.m. CEST.
Medtronic is estimated to report fiscal Q2 2027 results on November 17, 2026.

Medtronic plc, IE00BTN1Y115, Illustration mit AI erstellt.

On October 14, 2026, Piper Sandler maintained a Hold rating on Medtronic and set a USD 85.00 price target, according to Markets Insider. Medtronic stock was trading at EUR 83.69 at Lang & Schwarz on October 21, 2026 at 4:35 p.m. CEST.

Revenue reached USD 9.76 billion

Medtronic reported USD 9.76 billion in revenue for fiscal Q1 2027, ended July 31, 2026, up 13.70 percent from the prior-year quarter. Adjusted earnings per share reached USD 1.45, while GAAP earnings per share were USD 1.14, according to Yahoo Finance.

The comparison contains an important calendar effect. The quarter included an extra fiscal week that contributed USD 570.00 million to organic revenue, according to the same report. That item makes the 13.70 percent reported growth figure less representative of a standard quarter.

Price range and valuation

On the NYSE, Medtronic was trading at USD 93.89 on October 21, 2026 at 10:43 a.m. ET. The session range was USD 93.11 to USD 95.30, while the 52-week range stood at USD 73.31 to USD 106.33. Trading volume reached 1,464,153 shares by that timestamp.

Medtronic's market capitalization was USD 120.1 billion, and its price-to-earnings ratio was 23.16 on October 21, 2026. The company is listed on the NYSE under MDT and is a member of the S&P 500.

November 17 results date

Medtronic is estimated to report fiscal Q2 2027 results on November 17, 2026, before the US market opens. The estimate calls for revenue of USD 9.48 billion and earnings per share of USD 1.34, compared with USD 8.96 billion and USD 1.36 in the year-earlier quarter, according to MarketBeat.

What the target says

Piper Sandler's USD 85.00 target is below the October 14 NYSE price, while the next earnings report will test whether the fiscal Q1 growth rate can continue without an extra selling week.

The further course of trading is shown by the continuously updated real-time quote of Medtronic stock.